Effectiveness evaluation of hemibody irradiation as palliative treatment of patients with multiple painful bone dissemination
Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 5
Abstract
Effectiveness of hemibody irradiation (HBI) of 61 patients with multiple painful bone dissemination treated between 2001-2004 was evaluated. 21 patients had UHBI and 40 LHBI. Pain intensity on an 11-degree scale, pain frequency on a 4-degree scale and the kind of analgesics used were evaluated. Patients were examined on HBI day, 2 weeks later and next, every month. Dependencies between pain before HBI and pain relief 2 and 6 weeks later were checked. Pain 2 and 6 weeks after U and LHBI, and pain relief at that time for breast and prostate patients were compared. Mean pain intensity on HBI day was 6.3 and decreased to 3.0 after 2 weeks. Subsequent values were 4.0, 3.0, 3.0, 4.5, 2.0 and 3.4 six months later. Mean pain frequency on HBI day was 3.1 and did not change significantly (from 2.8 to 3.0). On HBI day 3.4% of patients did not use analgesics, 31% used NSAID, 8.6% tramadol, 10.3% opioids, 10.3% NSAID+tramadol and 36.2% NSAID+opioids, so 46.5% used opioids. A percentage of patients without analgesics increased to 37.5% and a percentage using opioids decreased to 25% 3.5 months later. Dependency between pain before HBI and pain relief 2 weeks later was found. Pain relief 2 and 6 weeks after HBI was higher for breast than for prostate patients. No difference between U and LHBI effectiveness was found. Obtained results allow us to conclude that HBI is an effective and simple treatment modality for patients with multiple painful skeletal dissemination allowing an analgesics intake to be decreased.
Authors and Affiliations
Leszek Miszczyk, Aleksandra Gaborek, Jerzy Wydymański
Keywords
Related Articles
- EP ID EP82293
- DOI -
- Views 55
- Downloads 0
Przerzuty do ośrodkowego układu nerwowego u chorych na rozsianego raka piersi leczonych trastuzumabem
Amplifikacja genu HER2 i/lub nadekspresja receptora HER2 występuje w 20–30 proc. inwazyjnych raków piersi i w 60 proc. raków śródprzewodowych. U chorych na inwazyjnego raka piersi zaburzenia genu HER2 związane są z bar...
The activity of N-acetyl-β-D-hexosaminidase in serum and urine of patients with pancreatic cancer
Background: N-acetyl-β-D-hexosaminidase (HEX) is lysosomal exoglycosidase (EC 3.2.1.52), which releases N-acetyloheksozoamines from non reducing ends of oligosaccharide chains of glycoconjungates (glycoproteins, glycoli...
c-myc oncogene aberration in breast cancer patients assessed by direct double differential PCR
Breast cancer is the most frequent tumour diagnosed in women, especially in well-developed countries. One of the genes of the highest interest in its diagnosis and prognosis is protooncogene c-myc, which plays a role as...
Czerniak nosowej części gardła leczony radioterapią – opis przypadku
Zdaniem wielu autorów pierwotny czerniak śluzówki regionu głowy i szyi powinien być leczony chirurgicznie, z ewentualną radioterapią uzupełniającą. Autorzy artykułu leczyli samodzielną radioterapią chorą na nieoperacyjne...
Leczenie celowane chorych na raka jelita grubego – aktualny stan wiedzy
Ostatnie osiągnięcia w dziedzinie terapii celowanej przyniosły chorym na raka jelita grubego dalszą poprawę przeżycia. Szczególne znaczenie kliniczne uzyskały 2 przeciwciała monoklonalne skierowane przeciw naczyniowemu...